Please login to the form below
Digital intelligence blog
Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools
The digital shift in pharma marketing
23 Jan 2020
Indegene’s surveys in 2016 and 2019 show a spike in digital spend
How AI is transforming the way we collect market insights02 Jan 2020
Leveraging new technologies to gather actionable insights
Pharma’s race to digital17 Dec 2019
AI: opportunities and barriers to improving healthcare26 Nov 2019
How AI is shaping the future of healthcare
Four digital health trends set to reinvent and re-energise pharma21 Nov 2019
Why AI is set to transform the nature of healthcare
Indegene Pharma Marketer 2020 Report predicts significant shift in channel spends 07 Nov 2019
Content personalisation to continue to yield disproportionate returns
Healthcare’s voice revolution29 Oct 2019
With the UK’s NHS unveiling a major partnership with Amazon’s Alexa, is pharma in danger of being left behind?
How technology is driving new trends in patient engagement07 Oct 2019
by Alicia Staley
The business case for patient engagement03 Oct 2019
Using digital to bridge the engagement gap between patients and pharma
Transformation in healthcare professionals’ digital behaviours01 Oct 2019
How HCPs use digital technology – and how to understand their behaviours
Share
Featured jobs
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Account Director or Senior Account Director
-
Salary TBC
-
Vice President
-
Competitive Salary Offered
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
-
Consultant
-
competitive salary
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
Subscribe to our email news alerts
- Lilly will aim for one $1bn-$5bn deal per quarter in 2020
- Novartis links up with NHS for speedy access to cholesterol drug inclisiran
- NICE leaves the ‘the NHS door’ open despite rejecting Bayer’s Vitrakvi
- Immuno-oncology, personalised medicine continues to drive pharma sector
- FDA delays decision on Intercept's NASH drug by three months
- Novartis gets EU approval for multiple sclerosis therapy Mayzent
- New coronavirus sees drug developers scramble to develop a vaccine
- Sanofi completes acquisition of immuno-oncology specialist Synthorx
- Roche's checkpoint inhibitor fails pivotal urothelial cancer trial
- Epizyme wins FDA approval for epithelioid sarcoma treatment
- Pharma Brand Planners' Blog (Part 8)
- Happy Chinese New Year 2020 - The Year of The Rat
PMHub
bmore group
OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....
Latest intelligence
- Happy Chinese New Year 2020 - The Year of The Rat
- A fond farewell to The Year of the Pig...
- White Paper for download - Explaining the price of your product
- In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
- OPEN Health expands offering with the launch of a new Learning & Development specialist team
- Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Quick links
Infographics
